Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Outside Perspectives Beget Better Outcomes

Posted on January 26th, 2016 by in Pharma R&D

My favorite quote about why drug discovery, despite very productive decades of productivity and innovation, has seemed to have reached the drought is from Ashutosh Jogalekar in Scientific American blog: Continue reading “Outside Perspectives Beget Better Outcomes” »

Gender gap, the leaking pipeline of R&D

Posted on January 21st, 2016 by in Pharma R&D

I guess we all worked out that half of the people on this planet are male and the other half are female. If you even sporadically read the papers you must have stumbled upon some sort of article quoting numbers such as Continue reading “Gender gap, the leaking pipeline of R&D” »

EMA Yearly Update on MLM – highlights and next steps

Posted on January 19th, 2016 by in Pharmacovigilance

EMA  Pharmacovigilance Programme Update Issue 6 – Preparing for Business Change

Since July 2014, EMA provides quarterly Pharmacovigilance Programme Updates to Marketing Authorisation Holders (MAHs). Continue reading “EMA Yearly Update on MLM – highlights and next steps” »

Unmixing the messages

Posted on January 18th, 2016 by in Pharma R&D

Have you ever driven through a red light because you were looking at the wrong traffic signal? Or had a row of angry motorists behind you because you hadn’t realized the signal above your lane had turned green? Continue reading “Unmixing the messages” »

  1. 1
  2. 2
  3. 3